111 related articles for article (PubMed ID: 11766340)
1. [Chemotherapy and radiation therapy].
Matsuo T; Tomonaga M
Nihon Rinsho; 2001 Dec; 59(12):2364-8. PubMed ID: 11766340
[TBL] [Abstract][Full Text] [Related]
2. Chronic myelogenous leukemia: a review.
Cortes JE; Talpaz M; Kantarjian H
Am J Med; 1996 May; 100(5):555-70. PubMed ID: 8644769
[TBL] [Abstract][Full Text] [Related]
3. [Interferon-alpha in the treatment of chronic myeloid leukemia].
Guilhot F
Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
[No Abstract] [Full Text] [Related]
4. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
O'Brien SG; Guilhot F; Larson RA; Gathmann I; Baccarani M; Cervantes F; Cornelissen JJ; Fischer T; Hochhaus A; Hughes T; Lechner K; Nielsen JL; Rousselot P; Reiffers J; Saglio G; Shepherd J; Simonsson B; Gratwohl A; Goldman JM; Kantarjian H; Taylor K; Verhoef G; Bolton AE; Capdeville R; Druker BJ;
N Engl J Med; 2003 Mar; 348(11):994-1004. PubMed ID: 12637609
[TBL] [Abstract][Full Text] [Related]
5. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE
Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
[TBL] [Abstract][Full Text] [Related]
6. Uncommon long-term survival in a patient with chronic myeloid leukemia.
Stagno F; Vigneri P; Stagno F; Vigneri P; Del Fabro V; Stella S; Berretta S; Massimino M; Tirrò E; Messina A; Di Raimondo F
Acta Oncol; 2009; 48(8):1215-6. PubMed ID: 19863235
[No Abstract] [Full Text] [Related]
7. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.
Kantarjian HM; Talpaz M
Semin Oncol; 1994 Dec; 21(6 Suppl 14):8-13. PubMed ID: 7992099
[TBL] [Abstract][Full Text] [Related]
8. Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemia.
Kantarjian HM; Talpaz M; Smith TL; Cortes J; Giles FJ; Rios MB; Mallard S; Gajewski J; Murgo A; Cheson B; O'Brien S
J Clin Oncol; 2000 Oct; 18(20):3513-21. PubMed ID: 11032593
[TBL] [Abstract][Full Text] [Related]
9. [Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
Arana-Trejo RM; Ovilla-Martínez R; Gómez-Morales E; Meillon-García L; Cervantes-Peredo A; González-Llaven J; Pizzuto-Chávez J; Kofman-Alfaro S
Rev Invest Clin; 1997; 49(3):209-14. PubMed ID: 9380976
[TBL] [Abstract][Full Text] [Related]
10. Results of decitabine (5-aza-2'deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia.
Kantarjian HM; O'Brien S; Cortes J; Giles FJ; Faderl S; Issa JP; Garcia-Manero G; Rios MB; Shan J; Andreeff M; Keating M; Talpaz M
Cancer; 2003 Aug; 98(3):522-8. PubMed ID: 12879469
[TBL] [Abstract][Full Text] [Related]
11. Final analysis of the efficacy and safety of omacetaxine mepesuccinate in patients with chronic- or accelerated-phase chronic myeloid leukemia: Results with 24 months of follow-up.
Cortes JE; Kantarjian HM; Rea D; Wetzler M; Lipton JH; Akard L; Khoury HJ; Michallet M; Guerci-Bresler A; Chuah C; Hellmann A; Digumarti R; Parikh PM; Legros L; Warzocha K; Baccarani M; Li E; Munteanu M; Nicolini FE
Cancer; 2015 May; 121(10):1637-44. PubMed ID: 25586015
[TBL] [Abstract][Full Text] [Related]
12. Primary distal femur T-cell lymphoma after allogeneic haematopoietic stem cell transplantation for chronic myeloid leukaemia: a rare case report and literature review.
Han Q; Sun M; Wu L; Chen J; Wang W; Liu C; Chen H; Du G
J Int Med Res; 2014 Apr; 42(2):598-605. PubMed ID: 24501166
[TBL] [Abstract][Full Text] [Related]
13. Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation.
Wassmann B; Klein SA; Scheuring U; Pfeifer H; Martin H; Gschaidmeier H; Hoelzer D; Ottmann OG
Bone Marrow Transplant; 2001 Oct; 28(7):721-4. PubMed ID: 11704799
[TBL] [Abstract][Full Text] [Related]
14. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
15. Studies of decitabine with allogeneic progenitor cell transplantation.
Giralt S; Davis M; O'Brien S; van Besien K; Champlin R; de Vos D; Kantarjian H
Leukemia; 1997 Mar; 11 Suppl 1():S32-4. PubMed ID: 9130690
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategies for chronic myeloid leukemia in the chronic (stable) phase.
Goldman JM
Semin Hematol; 2003 Jan; 40(1 Suppl 1):10-7. PubMed ID: 12682876
[TBL] [Abstract][Full Text] [Related]
17. Incidence and management of myelosuppression in patients with chronic- and accelerated-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate.
Akard L; Kantarjian HM; Nicolini FE; Wetzler M; Lipton JH; Baccarani M; Jean Khoury H; Kurtin S; Li E; Munteanu M; Cortes J
Leuk Lymphoma; 2016; 57(3):654-65. PubMed ID: 26436949
[TBL] [Abstract][Full Text] [Related]
18. Early treatment decisions with interferon-alfa therapy in early chronic-phase chronic myelogenous leukemia.
Sacchi S; Kantarjian HM; Smith TL; O'Brien S; Pierce S; Kornblau S; Beran M; Keating MJ; Talpaz M
J Clin Oncol; 1998 Mar; 16(3):882-9. PubMed ID: 9508169
[TBL] [Abstract][Full Text] [Related]
19. New strategies in chronic myeloid leukemia.
Kantarjian HM; Cortes J
Int J Hematol; 2006 May; 83(4):289-93. PubMed ID: 16757426
[TBL] [Abstract][Full Text] [Related]
20. [Complete cytogenetic remission of chronic myeloid leukemia with low-dose interferon alfa-2b and monthly high-dose busulfan].
Armenta D; Espallargas C; Paz A; Rodríguez Martorel J; Ladines R; Alvarez C; Román J; Andrés P
Sangre (Barc); 1996 Dec; 41(6):465-7. PubMed ID: 9148424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
